Suchergebnisse - (Subject:"Pneumonia")

PubPharm (1.651)

1

Changing clinical characteristics of pediatric inpatients with pneumonia during COVID-19 pandamic : a retrospective study

enthalten in: Italian journal of pediatrics | 2024

von Chen, M. | Zhou, Y. | Jin, S. | +11

2

Changing clinical characteristics of pediatric inpatients with pneumonia during COVID-19 pandamic: a retrospective study

enthalten in: The Italian journal of pediatrics | 2024

von Chen, M. | Zhou, Y. | Jin, S. | +11

3

Epstein-Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19

enthalten in: Intensive care medicine experimental | 2024

von Mattei, A. | Schiavoni, L. | Riva, E. | +10

4

Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19

enthalten in: Intensive Care Medicine Experimental | 2024

von Mattei, A. | Schiavoni, L. | Riva, E. | +10

5

The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infection

enthalten in: Biochimica et biophysica acta. Molecular basis of disease | 2024

von Fernández, J. | Marín, A. | Rosales, R. | +28

6

Clinical characteristics of COVID-19 infection in patients undergoing hemodialysis

enthalten in: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences | 2024

von Zhu, J. | Zhao, Y. | Huang, W. | +4

7

Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia : Reparixin 1200 mg TID as add-on to SoC to Limit Disease Progression in Hospitalised Patients With COVID-19 and Other Community-Acquired Pneumonia. A Multicentre, Randomised, Double-blinded, Placebo-controlled, Phase III Trial (REPAVID-22)

enthalten in: ClinicalTrials.gov | 2024

8

Differences in clinical characteristics of early-onset and late-onset severe acute respiratory syndrome coronavirus 2 infections in neonates

enthalten in: European journal of pediatrics | 2024

von Wu, Y. | Wang, D. | Zhao, R. | +4

9

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia : A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Adult Hospitalized Subjects With CAP Including COVID-19 Pneumonia.

enthalten in: ClinicalTrials.gov | 2024

10

A Systematic Review: Classification of Lung Diseases from Chest X-Ray Images Using Deep Learning Algorithms

enthalten in: SN Computer Science | 2024

von Hage Chehade, A. | Abdallah, N. | Marion, J. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[166]